Predictors of AIS Unfavorable Outcomes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 592 participants.
Also called NCT06058884
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 592 participants
- Sponsor
- Registry
-
NCT06058884
-
- Other papers using this trial's data
- Predictors of the unfavorable outcomes in acute ischemic stroke patients treated with alteplase, a multi-center randomized trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Egypt
- Registry status
- Completed
Technical summary
Registry record NCT06058884. Randomized; no masking; primary purpose treatment. Start 2022-01-03 (actual); primary completion 2023-06-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Predictors of AIS Unfavorable Outcomes
- Condition
- Ischemic Stroke
- Condition
- Alteplase Adverse Reaction
- Intervention (Drug)
- Alteplase
- Lead sponsor
- Kafrelsheikh University
Record details
- Record id
cardio:ct-nct06058884- Content hash
8ce2df29e00ff9fb7922cb6b23b21a7c7629b30cf6ae8c7ef1510d77a1bb8145